Feedback

Prof. Balaram Ghosh 

Associate Professor,
Department of Pharmacy

Birla Institute of Technology & Science, Pilani
Hyderabad Campus
Jawahar Nagar, Kapra Mandal
Dist.-Medchal-500 078
Telangana, India

Research Group

Research Scholars

Graduated Research Scholars

Thesis Students (FD & HD)

  1. Sonali Kotagiri [HD_ID No: 2012H147061H] [Winter 2014]

Project: Design and Development of Novel Histone Deacetylase-3 (HDAC3) Inhibitors using Molecular Modeling Studies (Current position: USA)

Position: Researcher, USA 

  1. Srividya Bharathi Bhagavatula [FD_ID: 2015A5TS0863H] [Winter 2019]

Project: Synthesis of Anticancer Agents

  1. Gajraj Singh Rathore [FD_ID: 2015A5TS0869H] [Winter 2019]

Project: Exploring Mechanisms to Identify Response to Immune Checkpoint Inhibitors (ASTAR, Singapore)

Current position: University of Geneva, Switzerland

  1. Shilpa Elsa George [FD_ID:2016A5TS0738H] [Fall 2019]

Project: Spectroscopic Characterization of Nano-particle Molecule Interactions (Australia)

Current position: PhD student at University of Colorado, USA)

  1. Tania Dutta [FD_ID:2016A5TS0748H] [Fall 2019]

Project: Epigenetic Regulation of NF-kB in Cancer (NTU, Singapore)

Current position: Master Student in the department of neuroscience, Paris 

  1. Shivani Paritosh Naik [FD_ID:2016A5TS0729H] [Fall 2019]

Project: Tumor Stroma Penetrating Nanoparticles for Combination Therapy of Drug Resistant Kidney (Wayne State University, USA). Cancer Current position: University of New York, USA

  1. Nikhil Baheti(FD_ID: 2016A5TS0735H) [Winter 2020]

Project: Operations and Management of Pharmaceutical Products

  1. Chaiti Chatterjee (FD_ID: 2016A5TS0728H) [Fall 2020]

Project: Value creation in mergers & acquisitions deals involving pharmaceutical industries in India and the subsequent response of the consumers.

  1. Kondapaneni Likhitha Purna (HD_ID: 2019H1460148H) [Winter 2021]

Project: Development of Dual pH Sensitive HPMA Conjugated Polymeric System for Effective Delivery of Doxorubicin

  1. Shreya Nilay (FD_ID: 2018A5TS108 [Fall 2021]

Project: Development and Biological Applications of HDAC3 Inhibitors.

  1. Shraddha Dumawat (FD_ID: 2018A5TS1095H) [Fall 2021]

Project: Biomimetic Molecular Codes for Therapeutic Gene Modulation

  1. Rishitha Kaminedi (FD_ID: ID No. 2019A5PS1183H) [Fall 2022]

Project: Design, Synthesis and Physicochemical Characterization of HDAC3 inhibitor for Biological Application

  1. Auntara Nandi (FD_ID: 2018A5TS1078H) [Fall 2022]

Project: Generating higher affinity crystalline gamma s (CRYGS) mutants to reduce inflammation and cataract formation in the eye (Harvard University, USA)

  1. K. Naga Srinidhi (FD_ID: 2018A5B31069H) [Winter 2023]

Project: Investigation of the roles of proteolytic machineries of malaria parasites (CCMB, Hyderabad)

  1. Mahima Tejasvni Gupta [HD, ID No. 2018HS461079H] [Fall 2023]

Project title: Synthesis and scale up of CMD coated Iron oxide nanoparticles using Confined Impinging Jet mixer for tooth decay and biofilm prevention (Dr David Cormode’s Nanomedicine & Molecular Imaging Lab, University of Pennsylvania, USA

  1. Eesha Kancharla (FD: ID: 2020A5TS2574H) [Fall 2023]

Project Title: Impurity Profiling of Therapeutic Recombinant Monoclonal Antibody. (Serum Institute of India, Pune)

  1. Shivani Rakesh Gosalia (FD: ID: 2020A5TS2581H) [Fall 2023]

Project title: Screen for sleep-modifying compounds in Drosophila model of Huntington’s disease. (JNCASR)

  1. Abhiram P Ganorkar (FD: ID: 2020A5TS2597H) [Fall 2023]

Project Title: Simultaneous targeting of DPP-4 and HDAC3 by dual inhibitors for the treatment of Type 2 Diabetes

  1. Gade Mohitha (FD: ID: 2021A5TS1975H) [Fall 2024]

Project title: Development of transdermal formulation of Immunomodulators against melanoma

  1. Sampreeti Subudhi (FD: ID: 2021A5TS1572H] [Winter 2025]

Project title: Assessment of Indian Health System and Healthcare Financing

  1. Aritra Banerjee [FD: ID: 2021A5TS1571H] [Winter 2025]

Project title: Identification and Design of Selective HDAC3 – PROTACs as Anticancer Therapeutics

  1. Drishti Chatterjee [FD: ID: 2022A5TS1257H] [Fall 2025]

Project title: The selective and potent molecules will be further explored in in-vivo study for therapeutic potential amount

   23. Peddada Sai Sruthi [FD: ID:  2022A5TS2030H] [Fall 2025]

Project title: Regulatory and Intellectual property at Advagen Pharma that ensures drug marketing, approval and compliance with FDA at Rubican Research, New Jersey, USA